Eledon Pharmaceuticals's top three insider shareholders as of June 18, 2026 are Partners L P/Il Bvf (TenPercentOwner, 220.46K shares), David-Alexandre C Gros (Chief Executive Officer, 9.00K shares), Keith Katkin (Director, 8.57K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners L P/Il Bvf | - | 220,460 | 0 | 13 May, 2024 |
| Keith Katkin | - | 8,575 | 0 | 16 Jan, 2026 |
| John S. Mcbride | Chief Operating Officer | 3,430 | 0 | 16 Jan, 2026 |
| David-Alexandre C Gros | Chief Executive Officer | 9,000 | 0 | 21 Dec, 2021 |
| Steven Perrin | President | 1,000 | 0 | 23 Nov, 2022 |
| Jan Hillson | - | 3,430 | 0 | 16 Jan, 2026 |
| Allan Kirk | - | 3,430 | 0 | 16 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Jan, 2026 | Allan Kirk | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | Keith Katkin | Common Stock | A | 8,575 | $0.00 | 8,575 | D | M |
| 10 Jan, 2026 | Allan Kirk | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | Jan Hillson | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | Jan Hillson | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | John S. Mcbride | Common Stock | A | 3,430 | $0.00 | 3,430 | D | M |
| 10 Jan, 2026 | John S. Mcbride | Restricted Stock Units | D | 3,430 | $0.00 | 0 | D | M |
| 10 Jan, 2026 | Keith Katkin | Restricted Stock Units | D | 8,575 | $0.00 | 0 | D | M |
| 10 Jan, 2026 | Jan Hillson | Restricted Stock Units | D | 3,430 | $0.00 | 0 | D | M |
| 10 Jan, 2026 | Jan Hillson | Restricted Stock Units | D | 3,430 | $0.00 | 0 | D | M |
| 10 Jan, 2026 | Allan Kirk | Restricted Stock Units | D | 3,430 | $0.00 | 0 | D | M |
| 10 Jan, 2026 | Allan Kirk | Restricted Stock Units | D | 3,430 | $0.00 | 0 | D | M |
| 10 Jan, 2025 | Jan Hillson | Stock Option (right to buy) | A | 30,870 | $0.00 | 30,870 | D | A |
| 10 Jan, 2025 | Allan Kirk | Stock Option (right to buy) | A | 30,870 | $0.00 | 30,870 | D | A |
| 10 Jan, 2025 | David-Alexandre C Gros | Stock Option (right to buy) | A | 600,000 | $0.00 | 600,000 | D | A |
| 10 Jan, 2025 | Steven Perrin | Stock Option (right to buy) | A | 243,000 | $0.00 | 243,000 | D | A |
| 10 Jan, 2025 | Jan Hillson | Stock Option (right to buy) | A | 30,870 | $0.00 | 30,870 | D | A |
| 10 Jan, 2025 | Allan Kirk | Stock Option (right to buy) | A | 30,870 | $0.00 | 30,870 | D | A |
| 10 Jan, 2025 | Keith Katkin | Stock Option (right to buy) | A | 77,175 | $0.00 | 77,175 | D | A |
| 10 Jan, 2025 | Steven Perrin | Stock Option (right to buy) | A | 243,000 | $0.00 | 243,000 | D | A |